Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Since Adage has between a 5% and 10% position if they had sold as much as 1% they would have been to disclose it within a few days, so it's encouraging that they haven't. I agree that the significant drop in short interest is encouraging as well. Short interest is now where it was in 2014 when the stock was in the $3s before the run to $30. We just need a catalyst now to move back up. IMO the $2 offering sealed the fate of Tony (Do Nothing) Lombardo and Sarah (am I really a CFO) Bonstein being shown the exit. Hopefully Berlin will prove to be a good CEO and salvage the shareholder value destroyed over the last three years.